4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-20-006667
Chief Financial Officer gave up 1,308 shares (to pay taxes)
- Chief Financial Officer acquired 3,875 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ruffo Frank Chief Financial Officer | 2020-02-03 | Option exercise | +3,875 | 170,675 | D: show line 1 in the form | ||
| Ruffo Frank Chief Financial Officer | 2020-02-03 | Shares withheld for taxes | −1,308 | $1.28 | $1,674 | 169,367 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ruffo Frank Chief Financial Officer | 2020-02-03 | Option exercise · Restricted Stock Units | −3,875 | 7,750 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…